Core Insights - The company Yimai Sunshine (02522) announced the launch of the world's first AI-assisted diagnostic product, AIR, developed by its affiliated AI company, Shanghai Yinghe Medical Technology Co., Ltd. This product marks a significant advancement in medical imaging AI, transitioning from the "single disease small model" era to the "foundation model-driven" era, showcasing capabilities for comprehensive diagnosis across multiple organs and diseases [1][2] Group 1 - The AIR product focuses on chest CT scans, enabling simultaneous detection and diagnosis of all common diseases in the lungs, pleura, and mediastinum with a single scan [1] - AIR is based on the world's first cross-modal, full-process medical imaging foundation model, "Yinghe Mijia," which enhances diagnostic efficiency, precision, and seamless integration [1][2] - The launch of AIR signifies a shift from "single-point breakthroughs" to "systematic empowerment" in medical imaging AI, transforming the industry from "single disease detection" to "multi-disease collaborative analysis" [2] Group 2 - AIR serves as the first commercial outcome of the Yinghe Medical foundation model ecosystem, connecting top hospitals with grassroots medical institutions to create a positive feedback loop for data-driven model iteration and scene implementation [2] - This model is expected to significantly shorten AI product development cycles, reduce costs, and promote standardized screening, intelligent diagnosis, and inclusive services across the healthcare industry [2] - The technological innovation of "one scan, multiple disease simultaneous diagnosis" is anticipated to enhance the competitiveness and added value of the company's imaging center services [2]
一脉阳光(02522)：影禾医脉发布全球首个基座大模型驱动的AI辅助诊断产品